These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 497404)

  • 1. Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin.
    Mustard JF; Kinlough-Rathbone RL; Packham MA; Perry DW; Harfenist EJ; Pai KR
    Blood; 1979 Nov; 54(5):987-93. PubMed ID: 497404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets.
    Kornecki E; Niewiarowski S; Morinelli TA; Kloczewiak M
    J Biol Chem; 1981 Jun; 256(11):5696-701. PubMed ID: 6263888
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognition of platelet-associated fibrinogen by polyclonal antibodies: correlation with platelet aggregation.
    Peerschke EI
    Blood; 1992 Apr; 79(8):2028-33. PubMed ID: 1562729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fibrinogen with human platelets pretreated with chymotrypsin or aggregated with ADP or thrombin: an immunocytochemical study.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Yamazaki H; Mustard JF
    Br J Exp Pathol; 1989 Aug; 70(4):479-88. PubMed ID: 2765399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia.
    Coller BS
    Blood; 1980 Feb; 55(2):169-78. PubMed ID: 6766334
    [No Abstract]   [Full Text] [Related]  

  • 7. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
    Heyns Adu P; Eldor A; Yarom R; Marx G
    Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
    Kornecki E; Tuszynski GP; Niewiarowski S
    Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 Apr; 71(4):850-60. PubMed ID: 2833330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS; Peerschke EI; Scudder LE; Sullivan CA
    J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets.
    Peerschke EI; Coller BS
    Blood; 1984 Jul; 64(1):59-63. PubMed ID: 6733283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
    McGregor L; Hanss M; Sayegh A; Calvette JJ; Trzeciak MC; Ville D; Catimel B; Viala JJ; Dechavanne M; McGregor JL
    Thromb Haemost; 1989 Nov; 62(3):962-7. PubMed ID: 2595666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of collagen-induced fibrinogen binding to human platelets.
    Legrand C; Dubernard V; Nurden AT
    Biochim Biophys Acta; 1985 Feb; 812(3):802-10. PubMed ID: 3970909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients.
    Cattaneo M; Kinlough-Rathbone RL; Lecchi A; Bevilacqua C; Packham MA; Mustard JF
    Blood; 1987 Jul; 70(1):221-6. PubMed ID: 3109523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the effects of cytochalasin B and cytochalasin D on ADP- and chymotrypsin-treated platelets.
    Peerschke EI
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):109-15. PubMed ID: 6694966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of blood platelet function induced by neutral proteases from human leukocytes.
    Bykowska K; Kaczanowska J; Karpowicz M; Lopaciuk S; Kopeć M
    Thromb Res; 1985 Jun; 38(5):535-46. PubMed ID: 3892761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.